Cargando…
Sensitization to the mitochondrial pathway of apoptosis augments melanoma tumor cell responses to conventional chemotherapeutic regimens
Metastatic malignant melanoma is highly resistant to chemotherapy, and the average survival rate is under 1 year. The only FDA-approved conventional chemotherapy (i.e., dacarbazine) targets melanoma tumor cells by inducing a form of cell death referred to as apoptosis. However, dacarbazine exhibits...
Autores principales: | Anvekar, R A, Asciolla, J J, Lopez-Rivera, E, Floros, K V, Izadmehr, S, Elkholi, R, Belbin, G, Sikora, A G, Chipuk, J E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542597/ https://www.ncbi.nlm.nih.gov/pubmed/23152056 http://dx.doi.org/10.1038/cddis.2012.161 |
Ejemplares similares
-
Born to be Alive: A Role for the BCL-2 Family in Melanoma Tumor Cell Survival, Apoptosis, and Treatment
por: Anvekar, Rina A., et al.
Publicado: (2011) -
Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAF(V600E) inhibition and can be targeted to reduce resistance
por: Serasinghe, Madhavika N., et al.
Publicado: (2014) -
Putting the pieces together: How is the mitochondrial pathway of apoptosis regulated in cancer and chemotherapy?
por: Elkholi, Rana, et al.
Publicado: (2014) -
Metabolic interrogation as a tool to optimize chemotherapeutic regimens
por: Sandulache, Vlad C., et al.
Publicado: (2017) -
Bleomycin Containing Chemotherapeutic Regimen Induced Acquired Partial Lipodystrophy
por: Tandon, Vishal R, et al.
Publicado: (2016)